Commodore Capital’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-217,253	Closed	-$8.79M	–	30
2023 Q1	$8.79M	Sell	217,253 -6,241	-3%	-$252K	1.34%	23
2022 Q4	$10.4M	Buy	223,494 +120,000	+116%	+$5.58M	1.57%	22
2022 Q3	$5.37M	Buy	+103,494	New	+$5.37M	0.86%	23